Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of the study is to compare the bioavailability of a generic product of metoprolol with that of a reference product when administered to healthy volunteers under fasting conditions. The test product is BF-Metoprolol Tablets 100mg manufactured by Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited and the reference product is Betaloc Tablet 100mg. The plasma kinetic data of metoprolol obtained from two formulations will be used to access the interchangeability of the products.
Epistemonikos ID: 48b09d821cbda1216bea56106c926409ad72824d
First added on: May 20, 2024